The invention provides pet tear
stain eye drops containing
haematococcus pluvialis extract, the pH value of the eye drops is 6.8-7.2, the
osmotic pressure is 280-320 mOsm / kg, the
viscosity is 3-8 mPa.s (25 DEG C), and the eye drops comprise the following components in percentage by
mass: 0.05-0.5% of
haematococcus pluvialis
astaxanthin extract (based on the
astaxanthin content being greater than or equal to 5%), 0.05-0.5% of a pH
regulator (based on the
astaxanthin content being greater than or equal to 5%), and the balance of water. 1%-3% of an anti-inflammatory
plant compound; 0.5%-1.2% of an isoosmotic adjusting agent; 0.2%-0.8% of a nano carrier stabilizer; 0.01%-0.1% of a pH buffer agent; compared with the prior art, the invention has the following beneficial effects: the corneal permeability of the astaxanthin is increased to 82% (measured by a Franz
diffusion cell) through
PLGA coating, and is increased by 5.5 times compared with the corneal permeability of the astaxanthin in a
free state (15%); natural
tocopherol is reserved through supercritical CO2 extraction (the content of the natural
tocopherol is larger than or equal to 0.5% through HPLC detection), and the
retention rate of the astaxanthin stored at 40 DEG C for 90 days is larger than or equal to 90% through
Calendula quercitrin inhibits the expression of IL-6 (
enzyme-linked immunosorbent
assay (ELISA) detection is reduced by 76%), and chamomile
bisabolol blocks a COX-2 pathway.